PrimeRFP SCOUT · Federal Contract Recompete Brief

HT942526FE005Development of NOVEL DRUG particles for — Crititech Particle Engineering Solutions, LLC

Crititech Particle Engineering Solutions, LLC holds $318K across 4 federal awards, concentrated at Department of Defense (DOD). Recompete timing centers on the Dec 2, 2026 PoP end — agencies typically plan 12–18 months ahead.

Army Med Res Acq Activity
Awarding office
Crititech Particle Engineering Solutions, LLC
Recipient
Dec 2, 2026
PoP end
$141K
Obligated
$141K
Potential
541715
NAICS
AJ11
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Crititech Particle Engineering Solutions, LLC — $90

Contract facts

Federal
Contract numberHT942526FE005
Also listed asHT942524D0011-HT942526FE005
AgencyArmy Med Res Acq Activity
Awarding officeArmy Med Res Acq Activity
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentCrititech Particle Engineering Solutions, LLC
CAGE7UD60
UEIQMLLX81RZ6V9
NAICS541715
PSCAJ11
Parent IDIQ / IDVHT942524D0011
Place of performanceLAWRENCE KS
Pricing typeFirm Fixed Price
Extent competedNot Competed
PoP startDec 3, 2025
PoP end (current)Dec 2, 2026
Obligated$141K
Current value$141K
Potential value$141K

DEVELOPMENT OF NOVEL DRUG PARTICLES FOR INHALATIONAL THERAPY is a federal award for Army Med Res Acq Activity held by Crititech Particle Engineering Solutions, LLC. Estimated value $141K ($141K obligated). Current period of performance ends Dec 2, 2026. Place of performance: LAWRENCE KS.

DEVELOPMENT OF NOVEL DRUG PARTICLES FOR INHALATIONAL THERAPY

Recompete timing

Public
Expiring in 86 days

Current PoP ends Dec 2, 2026 (86 days remaining). Agencies typically plan 12–18 months ahead — at 2.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Crititech Particle Engineering Solutions, LLC$318K obligated across 4 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)
Department of Defense (DOD)$318K · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract HT942526FE005?

HT942526FE005 (Development of NOVEL DRUG particles for) is a Army Med Res Acq Activity award with a potential value of $141K, currently held by Crititech Particle Engineering Solutions, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded HT942526FE005?

Army Med Res Acq Activity awarded HT942526FE005 to Crititech Particle Engineering Solutions, LLC (potential $141K).

Who is the incumbent on HT942526FE005?

Crititech Particle Engineering Solutions, LLC is the incumbent with $318K across 4 related awards in SCOUT’s public footprint. The current period of performance ends Dec 2, 2026.

When does Crititech Particle Engineering Solutions, LLC’s HT942526FE005 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 2, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on HT942526FE005 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HT942526FE005